When FOXP3 expression was measured, a significant increase was found both in the combination and full dose anti-TNFα groups, underscoring likely effects of both therapeutic regimens on some Treg functions, in accordance with recent findings in Rheumatoid Arthritis patients[26]. This evidence concerns the gene FOXP3 and rheumatoid arthritis.